FP7 takes off

The EU's largest ever funding programme for research and technological development, the Seventh Framework Programme (FP7), was launched on 1 January.

The programme cleared its final hurdle when it was adopted by the Council on 18 December 2006. The decision was widely expected following an agreement on a common position between the Parliament and Council in November. The common position meant that the decision could be adopted by the Environment Council without discussion.

With a total budget of €50.521 billion, FP7 will run for of seven years. An additional €2.7 billion has been earmarked for the Euratom programme on nuclear research, which will run for five years. EU Science and Research Commissioner Janez Potocnik hailed the FP7's approval as 'great day' for European Science. 'In financial terms, this is a major improvement over the last framework programme. In real terms, there are 40 per cent more funds on average per year,' he said.

FP7 will aim to build on the accomplishments of the previous research framework programme, and will be implemented through four specific programmes. The 'Cooperation' programme will support research cooperation in a number of key thematic areas. 'Ideas' will fund investigator-driven research through a newly created European Research Council (ERC). The 'People' programme will support training and researchers' career development, while 'Capacities' will fund the coordination and development of research infrastructure, regional research clusters, international cooperation and closer ties between science and society.

Featuring simpler instruments and streamlined procedures for funding and participation, FP7 should facilitate the greater participation by and cooperation between universities, research centres, small and medium sized enterprises (SMEs) and companies on a broad range of research areas. In doing so, the new programme should make headway on the goal of creating a European Research Area (ERA) - the equivalent of a 'common market' for research - to become the world's leading research area.

Under FP7, the highest portion of the budget will go to information and communication technologies (€9.11 billion), followed by health (€6.05 billion), transport (€4.18 billion) and nanotechnology (€3.5 billion), energy (€2.3 billion), and food, agriculture and biotechnology (€1.935 billion). Other budget lines include environmental research (€1.8 billion), space (€1.43 billion), security (€1.35 billion), and social-economic sciences and humanities (€610 million).

Political discussions on FP7 were first held back by the lack of agreement on the EU's financial perspectives for 2007 to 2013. Consensus among the EU's Heads of State and Government on the overall budget was needed before the FP7 budget could be set.

Subsequent negotiations addressed ethical questions related to EU funding for human embryonic stem cell research, the structure of the ERC and the risk-sharing finance facility.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...